GLAND — Gland Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹290.48bn
- IN₹272.61bn
- IN₹36.25bn
- 83
- 11
- 44
- 41
Annual cashflow statement for Gland Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,863 | 9,929 | 13,348 | 16,186 | 10,546 |
| Depreciation | |||||
| Non-Cash Items | -57.3 | -624 | -815 | -1,385 | -1,085 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5,774 | -3,241 | -7,472 | -7,996 | -7,288 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,853 | 7,009 | 6,049 | 7,908 | 3,640 |
| Capital Expenditures | -1,357 | -1,947 | -2,288 | -5,221 | -2,231 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,784 | -5,714 | -12,952 | -4,805 | 14,313 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,141 | -7,661 | -15,240 | -10,026 | 12,082 |
| Financing Cash Flow Items | -26.2 | -62.5 | -23.3 | -34 | -62.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -31.2 | -68.7 | 12,385 | 349 | 149 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,364 | -669 | 3,230 | -1,736 | 15,901 |